Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma

被引:20
作者
Gabusi, Andrea [1 ]
Gissi, Davide Bartolomeo [1 ]
Montebugnoli, Lucio [1 ]
Asioli, Sofia [2 ]
Tarsitano, Achille [3 ]
Marchetti, Claudio [3 ]
Balbi, Tiziana [4 ]
Helliwell, Timothy R. [5 ]
Foschini, Maria P. [2 ]
Morandi, Luca [2 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromuscular Sci, Sect Oral Sci, Bologna, Italy
[2] Bellaria Hosp, Dept Biomed & Neuromotor Sci, M Malpighi Sect Anat Pathol, Via Altura 3, I-40139 Bologna, Italy
[3] St Orsola Hosp, Unit Maxillofacial Surg, Bologna, Italy
[4] St Orsola Hosp, Unit Anat Pathol, Bologna, Italy
[5] Royal Liverpool Univ Hosp, Dept Cellular Pathol, Liverpool, Merseyside, England
关键词
Oral squamous cell carcinoma; Intratumoural heterogeneity; Field cancerization; Prognosis; INTRATUMOR GENETIC-HETEROGENEITY; GENOMIC HETEROGENEITY; TUMOR EVOLUTION; CANCER; HEAD;
D O I
10.1007/s00428-019-02656-z
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Genetic heterogeneity displayed by tumour cells (intratumoural heterogeneity, ITH) represents a diagnostic challenge when assessing tumour mutational profile. In oral squamous cell carcinoma (OSCC), ITH may be found both in tumour cells and in adjacent mucosa. Genetic heterogeneity of the adjacent mucosa can be interpreted as evidence of the field cancerization (field heterogeneity, FH). The aim of the study was to investigate the impact of intratumoural and intrafield heterogeneity on locoregional control. Ten OSCC patients (5 recurrent and 5 nonrecurrent) were studied. Multiple areas were sampled from the bulk of the tumour and the adjacent nonneoplastic mucosa. A panel of 10 tumour-specific OSCC driver genes was analysed for each sample and was used to calculate heterogeneity. Values were compared among recurrent and nonrecurrent OSCC. Mutational analysis highlighted that a single tumour sample has limited accuracy in assessing the genetic profiles of tumours. High values of ITH considering shared mutations between specimens were found in both recurrent and non-recurrent OSCC (p = 0.095). On the contrary, the intrafield genetic heterogeneity was significantly less frequently in the non-recurrent OSCC group (p = 0.032). Heterogeneity within each specimen calculated with variant allele frequency confirmed that there was better discrimination between recurrent and nonrecurrent groups using nonneoplastic adjacent mucosa than tumour tissue (p value 0.0006 and 0.0048 respectively). In agreement with the theory of field cancerization, intrafield genetic heterogeneity correlates with a higher risk of developing loco-regional recurrences and second primaries. In order to reduce the ITH effects, analysis of multiple tumour areas should be encouraged.
引用
收藏
页码:585 / 595
页数:11
相关论文
共 26 条
[1]   The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update [J].
Afgan, Enis ;
Baker, Dannon ;
van den Beek, Marius ;
Blankenberg, Daniel ;
Bouvier, Dave ;
Cech, Martin ;
Chilton, John ;
Clements, Dave ;
Coraor, Nate ;
Eberhard, Carl ;
Gruening, Bjoern ;
Guerler, Aysam ;
Hillman-Jackson, Jennifer ;
Von Kuster, Greg ;
Rasche, Eric ;
Soranzo, Nicola ;
Turaga, Nitesh ;
Taylor, James ;
Nekrutenko, Anton ;
Goecks, Jeremy .
NUCLEIC ACIDS RESEARCH, 2016, 44 (W1) :W3-W10
[2]  
Amin MA, 2017, GASTROENTEROL INSIGH, V8, DOI 10.4081/gi.2017.6914
[3]   Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma [J].
Cao, W. ;
Wu, W. ;
Yan, M. ;
Tian, F. ;
Ma, C. ;
Zhang, Q. ;
Li, X. ;
Han, P. ;
Liu, Z. ;
Gu, J. ;
Biddle, F. G. .
ONCOGENESIS, 2015, 4 :e175-e175
[4]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].
Ferlay, J. ;
Steliarova-Foucher, E. ;
Lortet-Tieulent, J. ;
Rosso, S. ;
Coebergh, J. W. W. ;
Comber, H. ;
Forman, D. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403
[5]   Intratumoral Heterogeneity in Recurrent Metastatic Squamous Cell Carcinoma of the Oral Cavity: New Perspectives Afforded by Multiregion DNA Sequencing and mtDNA Analysis [J].
Gabusi, Andrea ;
Gissi, Davide Bartolomeo ;
Tarsitano, Achille ;
Asioli, Sofia ;
Marchetti, Claudio ;
Montebugnoli, Lucio ;
Foschini, Maria Pia ;
Morandi, Luca .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2019, 77 (02) :440-455
[6]   Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].
Gerlinger, Marco ;
Rowan, Andrew J. ;
Horswell, Stuart ;
Larkin, James ;
Endesfelder, David ;
Gronroos, Eva ;
Martinez, Pierre ;
Matthews, Nicholas ;
Stewart, Aengus ;
Tarpey, Patrick ;
Varela, Ignacio ;
Phillimore, Benjamin ;
Begum, Sharmin ;
McDonald, Neil Q. ;
Butler, Adam ;
Jones, David ;
Raine, Keiran ;
Latimer, Calli ;
Santos, Claudio R. ;
Nohadani, Mahrokh ;
Eklund, Aron C. ;
Spencer-Dene, Bradley ;
Clark, Graham ;
Pickering, Lisa ;
Stamp, Gordon ;
Gore, Martin ;
Szallasi, Zoltan ;
Downward, Julian ;
Futreal, P. Andrew ;
Swanton, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892
[7]   Current topics in the epidemiology of oral cavity and oropharyngeal cancers [J].
Gillison, Maura L. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (08) :779-792
[8]   Drug Resistance in Cancer: An Overview [J].
Housman, Genevieve ;
Byler, Shannon ;
Heerboth, Sarah ;
Lapinska, Karolina ;
Longacre, Mckenna ;
Snyder, Nicole ;
Sarkar, Sibaji .
CANCERS, 2014, 6 (03) :1769-1792
[9]   Personalized oncology: Recent advances and future challenges [J].
Kalia, Madhu .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (01) :S11-S14
[10]  
Kikutake Chie, 2018, Oncotarget, V9, P33337, DOI 10.18632/oncotarget.26071